Profile
Robert A. Reed formerly worked at Merck & Co., Inc., as Director-Pharmaceutical Research & Development, Imunon, Inc., as Executive Director, VP-CMC & Technical Operations from 2012 to 2013, Jefferson-Pilot Corp., as Vice President, Aradigm Corp., as Vice President-CMC, Regulatory & Quality, Reata Pharmaceuticals, Inc., as Chief Technical Officer & Senior VP-CMC, and XenoPort, Inc., as Vice President-Pharmaceutical Operations in 2009.
Dr. Reed received his doctorate degree from The University of North Carolina at Charlotte.
Former positions of Robert Reed
| Companies | Position | End |
|---|---|---|
| XENOPORT, INC. | Corporate Officer/Principal | 31/12/2008 |
Jefferson-Pilot Corp.
Jefferson-Pilot Corp. Life/Health InsuranceFinance Provides life insurance, annuity policies, accident insurance, and operates a TV stations | Corporate Officer/Principal | 04/04/2006 |
| REATA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
| ARADIGM CORPORATION | Corporate Officer/Principal | - |
Training of Robert Reed
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Jefferson-Pilot Corp.
Jefferson-Pilot Corp. Life/Health InsuranceFinance Provides life insurance, annuity policies, accident insurance, and operates a TV stations | Finance |
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Aradigm Corp.
Aradigm Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for the treatment and prevention of respiratory diseases | Health Technology |
Imunon, Inc.
Imunon, Inc. BiotechnologyHealth Technology Engages in the provision of oncology drug development services | Health Technology |
Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics which regulates cellular metabolism and inflammation in serious neurologic diseases | Health Technology |
XenoPort, Inc.
XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Robert Reed
















